Company / Interest Expense per Share
TEVA PHARMACEUTICAL INDUSTRIES LTD Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.82
FY2025
5-year range
$0.82 / $0.93
FY2021-FY2025
Trend
-9.3%
vs FY2024
Sector context
#8 of 43
Health Care
What the data says
TEVA PHARMACEUTICAL INDUSTRIES LTD's interest expense per share of $0.82 is higher than 81% of companies in the Health Care sector (FY2025). Interest Expense per Share has fluctuated over the past 10 years, ranging from $0.81 in FY2019 to $957336.11 in FY2018.
Based on SEC 10-K filings.
0.82 in FY2025 with a 5-year CAGR of -1.5%. Top quartile in the Health Care sector.
Improved from $0.93 to $0.82 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -1.5%
- 10-Year CAGR
- -
Sector benchmark
-91.6% below sector average
Key checks
Key Insights
- In FY2025, interest expense per share decreased 9.3% year-over-year.
- Ranks #8 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2018.
- Lowest interest expense per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -9.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.82 | -9.3% |
| FY2024 | $0.90 | -2.9% |
| FY2023 | $0.93 | +9.4% |
| FY2022 | $0.85 | +4.0% |
| FY2021 | $0.82 | -7.5% |
| FY2020 | $0.88 | +9.1% |
| FY2019 | $0.81 | -100.0% |
| FY2018 | $957336.11 | +111160298.4% |
| FY2017 | $0.86 | -100.0% |
| FY2016 | $568158.17 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026